TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Stavanger Øyeklinikk Kilden AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,787
|
1,759
|
1,742 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
872
|
744
|
787 |
| Total assets |
1,175
|
1,056
|
1,246 |
| Current assets |
1,060
|
941
|
1,107 |
| Current liabilities |
950
|
842
|
1,044 |
| Equity capital |
225
|
214
|
201 |
| - share capital |
25
|
27
|
28 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
19.1%
|
20.3%
|
16.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
48.8%
|
42.3%
|
45.2% |
| Return on assets (ROA) |
74.2%
|
70.5%
|
63.2% |
| Current ratio |
111.6%
|
111.8%
|
106.0% |
| Return on equity (ROE) |
387.6%
|
347.7%
|
391.5% |
| Change turnover |
118
|
128
|
279 |
| Change turnover % |
7%
|
8%
|
19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.